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ABSTRACT
Objective: To examine the effect of early clinical and
demographic factors on occupational outcome, return to
work or awarded permanent disability pension in young
patients with chronic fatigue syndrome (CFS).
Design: Longitudinal cohort study.
Intervention: A written self-management programme
including a description of active coping strategies for
daily life was provided.
Setting, participants: Patients with CFS after
mononucleosis were evaluated at Department of
Neurology, Haukeland University Hospital during
1996–2006 (contact 1). In 2009 self-report
questionnaires were sent to all patients (contact 2).
Primary and secondary outcome measures:
Primary measure was employment status at contact 2.
Secondary measures included clinical symptoms, and
Fatigue Severity Scale (FSS) scores on both contacts,
and Work and Social Adjustment Scale (WSAS) at
contact 2.
Results: Of 111 patients at contact 1, 92 (83%) patients
returned the questionnaire at contact 2. Mean disease
duration at contact 1 was 4.7 years and at contact 2
11.4 years. At contact 1, 9 (10%) were part-time or full-
time employed. At contact 2, 49 (55%) were part-time or
full-time employed. Logical regression analysis showed
that FSS≥5 at contact 2 was associated with depression,
arthralgia and long disease duration (all at contact 1).
Conclusions: About half of younger patients with CFS
with long-term incapacity for work experienced marked
improvement including full-time or part-time employment
showing better outcomes than expected. Risk factors for
transition to permanent disability were depression,
arthralgia and disease duration.
INTRODUCTION
Chronic fatigue syndrome (CFS) is a complex
incapacitating illness of unknown cause.1 2
CFS is characterised by persistent/recurrent
post-exertional fatigue of at least 6 months’
duration accompanied by at least four of eight
speciﬁc symptoms including impaired short-
term memory or concentration, severe enough
to cause substantial reduction in previous
levels of occupational, educational, social or
personal activities; headache of a new type,
pattern or severity; muscle pain; multijoint
pain without swelling or redness; sore throat;
tender cervical or axillary lymph nodes; unre-
freshing sleep; post-exertional malaise (PEM),
an exaggerated fatigue response to previous
well tolerated activities.1 3 The clinical condi-
tion has received increased attention in the
past two decades from medical, psychological
and social security/insurance communities.
The term ‘Chronic Fatigue Syndrome’ was
coined in 1988 by the US Centers for Disease
Control (CDC) and the present case deﬁnition
was developed by a joint CDC/National
Institute of Health (NIH) international
working group.1 The excessive fatigue and
fatigue-ability with disproportionately pro-
longed recovery after exercise or activity differ-
entiate CFS from other fatigue conditions.
Recent population-based epidemiological
studies using the 1994 CDC case deﬁnition
have reported the overall CFS prevalence to be
71 and 190 per 100 000 persons, respectively,
in Olmsted County, Minnesota and three
regions of England.4 5 CFS occurs in indivi-
duals during peak years of employment (age
20–50) with female preponderance. Rates of
unemployment are high.6 Work-related phys-
ical and cognitive impairments are demon-
strable with prolongation and recurrence of
sickness absence episodes that can be the ﬁrst
Strengths and limitations of this study
▪ Two strengths of the study are very long prospect-
ive follow-up period and focus on employment.
▪ A limitation is that patients were recruited from a
tertiary centre.
▪ Long-term prognosis for young patients with
chronic fatigue syndrome after mononucleosis is
favourable for a large subgroup.
▪ More than half of the patients with long-term
incapacity for work are re-employed after mean
disease duration of 11.4 years.
▪ Factors associated with poor long-term prognosis
include depression, arthralgia and disease duration.
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step in a process leading to prolonged medical leave and
awarded disability beneﬁts.7
A small proportion of people that develop infectious
mononucleosis remain sick with CFS.8 A recent
follow-up study of the course and outcome of CFS in
adolescents after mononucleosis showed that most indi-
viduals recover; however 13 of 301 adolescents, 4%, all
female, met the criteria of CFS after 2 years.9
Knowledge about the natural history and prognostic
factors in CFS is important as it relates to several aspects
of the illness; information and advice to newly diagnosed
patients, planning of healthcare and rehabilitation
strategies that focus on volitional and social aspects of
re-employment.10 Being unable to fulﬁl valued and
expected social functions, including employment, can
have a dramatic impact on self-concept with need to
re-evaluate life goals, as well as increased stress on the
part of caregivers.11
Few patient-based longitudinal studies have examined
employment outcomes as measure of prognosis in the
case of CFS.12 13 The objectives of this two time point study
of a cohort of younger patients with CFS without systematic
intervention were to document the natural course of
illness and to identify predictors of work cessation or
re-entry into work force. Only patients with CFS subse-
quent to mononucleosis were included in this study.
We hypothesised that baseline clinical presentations
such as cognitive problems, pain and depression at the
time of referral in addition to severe fatigue and long
illness duration prior to the evaluation predict long-term
functional disability including unemployment and
awarded disability beneﬁts.
MATERIAL AND METHODS
Patients
The 111 young patients, mean age 23 year, participating
in this study were part of a larger cohort of 873 consecu-
tive patients referred from all over Norway to a specialist
chronic fatigue clinic at the Department of Neurology,
Haukeland University Hospital during 1996–2006, pub-
lished previously.14 All patients were interviewed and
examined by a specialist physician, HIN, who conﬁrmed
the diagnosis of CSF meeting the Centers for Disease
Control and Prevention (CDC) case deﬁnition.1 The
111 patients constitute all patients diagnosed with CSF
triggered by mononucleosis in the total cohort of 873
patients. The diagnosis of mononucleosis was based on
the physician report following the patient to our clinic.
A written self-management programme included infor-
mation about the illness to provide the patients with a
rationale and structural meaning for their illness experi-
ence.15 Active coping strategies for daily life included
graded activity planning; encouraging activity, but staying
within their physical limitations with consistent rest
periods to minimise ﬂuctuations in fatigue and symptoms.
To avoid occupational impairment and restore ability to
work the importance to keep contact with the local health
and rehabilitation services, and inform the employer was
stressed. The family doctor and the local National Sickness
Beneﬁt Scheme ofﬁce (NAV) received a specialist report
on the medical history and investigations, the clinical
characteristics and disability.16
The Norwegian Social and Insurance Scheme accepted
CFS as a medicolegal diagnosis entitled to sickness and
disability beneﬁts to compensate for income loss in
1995.17 To receive long-term sickness absence (SA) bene-
ﬁts a sickness certiﬁcate has to be issued by a physician
describing the cause of absence and plans for treatment.
A disability pension (DP) is given to individuals aged 18–
66 to compensate for permanent work-life exit before
scheduled age retirement after relevant treatment or
vocational rehabilitation.18
Primary outcome measures at long-term follow-up
were employment: return to part-time or full-time work,
or transition to ill-health retirement and receipt of per-
manent disability pension. Secondary outcomes were
self-rated scales of clinical change, fatigue, disability and
CFS somatic symptoms.
Contact 1. Initial baseline evaluation
All patients completed a questionnaire at referral that
included questions about the mode of clinical onset
(whether the fatigue appeared acutely or evolved grad-
ually over months) and duration of the illness.
Questions about presenting symptoms comprised the
presence or not of concentration or memory problems,
throat pain, enlarged or tender lymph nodes, myalgia,
muscle weakness, arthralgia, dyspepsia, weight change,
frequent micturition, photophobia, slurred vision, dizzi-
ness, tinnitus, sleep disturbances, depression, unstable
mood, palpitations, fever, increased sweating and head-
ache. PEM19 was assessed with the following question:
does physical activity inﬂuence fatigue; improving, no
effect, some worsening, much worsening?
Fatigue was self-rated by the Fatigue Severity Scale
(FSS).20 This is a nine-item questionnaire that assesses
the effect of fatigue on daily living. Each item is a state-
ment on fatigue that the participant rates from 1, ‘com-
pletely disagree’ to 7, ‘completely agree’. Examples of
the items in the questionnaire are: ‘My motivation is
lower when I am fatigued’, ‘Exercise brings on my
fatigue’ and ‘I am easily fatigued’. The average score of
the nine items represents the FSS score (minimum score
is 1 and maximum score is 7). Patients with a mean FSS
score >5 are deﬁned as having severe fatigue.21
Employment status was noted as employed full-time, part-
time or unemployed. Sick leave from work or study, long-
term SA beneﬁts and DP were registered. Employment or
studies at the time of the triggering mononucleosis were
registered.
Contact 2. Follow-up during 2009
Self-report questionnaires were sent to the patients in
2009 on average 6.5 years after contact 1. A clinical
symptom questionnaire included questions as to
2 Nyland M, et al. BMJ Open 2014;4:e005798. doi:10.1136/bmjopen-2014-005798
Open Access
group.bmj.com on July 31, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
presence or not of problems with concentration and
memory, throat pain, enlarged or tender lymph nodes,
myalgia, muscle weakness, arthralgia, dyspepsia, nausea,
weight change, frequent micturition, photophobia,
slurred vision, dizziness, tinnitus, sleep disturbances,
depression, unstable mood, palpitations, fever, increased
sweating and headache.
The Work and Social Adjustment Scale (WSAS) was
used to measure disability. It is a ﬁve-item scale that
assesses an individual`s ability to perform everyday activ-
ities including work, home management, family and
relationship interaction and social and private leisure
activities. Each of the ﬁve items was rated on a nine-
point scale ranging from 0 (not at all a problem) to 8
(severely impaired) so that the total scores range
between 0 and 40.22 The psychometric properties have
been validated in large patient with CFS cohorts con-
ﬁrming that WSAS is a reliable assessment tool for dis-
ability. High scores correlate with severe fatigue and
poor physical ﬁtness.16
Fatigue was self-rated by the FSS scale. Based on
change in FSS score change from baseline, contact 1,
the disease course was deﬁned; FSS change <−1 was
deﬁned as worsening course; FSS change ≥−1 and ≤1
was deﬁned as no change; FSS change >1 was deﬁned as
improvement. Self-rated global clinical outcome was
scored as worsening, stable, improvement and recovered.
Employment status, sickness and disability beneﬁts were
recorded providing objective evidence of disability.
The study was approved by the local ethics committee.
Informed, written consent was obtained from the patients.
Statistics
Student’s t test, χ2 test, Fisher’s exact test, and pair-wise
correlation test were performed when appropriate. The
FSS score was dichotomised and FSS score ≥5 deﬁned as
pathological fatigue. Stepwise backward logistic regres-
sion analyses were performed with dichotomised FSS
score at contact 2 as dependent variable. Stepwise back-
ward linear regression analyses with FSS at contact 2 and
WSAS as dependent variables were performed. STATA
V.12.0 was used for analyses.
RESULTS
In total, 111 patients participated in the baseline evalu-
ation. Postal questionnaires were completed and
returned by 92 (83%) of these patients on follow-up
(contact 2); 30 (33%) males and 62 (67%) females
(contact 2). The mean age of the patients at the onset
of CFS was 23.7 years (SD=7.3). Mean duration of CFS at
the time of contact 1 was 4.7 years (SD=4.0),
(median=3.2 years, IQR=1.9−6.4). Mean time from
debut of CFS to contact 2 was 11.4 years (SD=4.3;
median=10.3 years, IQR=8.5–13.5; range=4.7−23.8). At
the time of mononucleosis 43 (47%) were employed at
work and 48 (52%) were students (missing data in one
patient). We do not report any data on the 19 (17%)
who did not complete the follow-up.
Employment at contact 1(92 patients)
At contact 1 9 (10.2%) patients remained employed (1 full-
time and 8 part-time), 12 patients (13.5%) were students
and 70 patients (81%) were neither employed nor study-
ing (missing data in one patient). One patient (1%) was
receiving partial DP and 7 patients (8%) were receiving
full DP. Fourteen (15%) patients received partial long-
term SA beneﬁts, and 62 (67%) patients received full long-
term sickness SA (missing data in 8 patients).
Employment at contact 2 (primary measures; 92 patients)
At contact 2 24 (27%) were fully employed, 25 (28%)
were employed part-time and 40 (45%) were unemployed
(missing data in three patients). One patient (1%) was
a student. In total, 63 of 92 patients received DP or
sickness absence beneﬁts: 15 patients (17%) were
awarded partial DP and 39 (44%) received full DP for the
reduced working capacity, 6 patients (7%) got partial SA
beneﬁts and 3 patients (3%) full SA beneﬁts. One (1%)
unemployed patient was part-time student. Five (5%)
patients were employed at both contact 1 and contact
2. Figure 1 shows employment status at contact 1 and
contact 2.
Logistic regression analyses showed that being employed
at contact 2 was associated with lack of arthralgia (OR=0.3,
p=0.028) and reporting improvement (OR=1.8, p=0.062)
at contact 1. Another logistic regression analyses showed
that being employed at contact 2 was associated with low
FSS score at contact 2 (OR=0.53, p<0.001), lack of arthral-
gia (OR=0.40, p=0.041) and lack of concentration pro-
blems (OR=0.32, p=0.064), but none of the other
symptoms reported at contact 2.
Secondary measures
There was no correlation between FSS score at contact 2
and degree of PEM at contact 1 (p=0.57). There was no
correlation between mode of onset of fatigue after
mononucleosis (acute or taking months) and FSS score
at contact 2 (p=0.61). Neither was there any correlation
Figure 1 Employment status of patients with chronic fatigue
syndrome at first contact (contact 1) and follow-up (contact 2).
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between employment status at contact 2 and degree of
PEM at contact 1 (p=0.91) nor mode of onset (P=0.59).
There was no correlation between degree of PEM at
contact 1 and FSS score at contact 1 (p=0.99).
Based on FSS change from contact 1 to contact 2, 38
(44%; FSS improvement>1) improved, 42 (48%; FSS
change ≤1 and ≥−1) did not change and 7 (8%) wor-
sened (FSS change <−1). Based on self-assessment
10 (12%) had worsened, 14 (17%) were stable, 47 (57%)
had improved and 11 (13%) had recovered at contact 2.
The correlation between self-rated clinical change
between contact 1 and contact 2 and employment status
at contact 2 was r=0.54 (p<0.001). The correlation
between change in FSS from contact 1 to contact 2 and
employment status was r=0.30 (p=0.01). The correlation
between FSS score at contact 2 and employment was
r=0.51 (p<0.001). The correlation between WSAS score
and employment was r=0.74 (p<0.001). The correlation
between WSAS score and FSS score at contact 2 was
r=0.81 (p<0.001).
Clinical characteristics based on evaluation at
contact 1 and contact 2 are shown in table 1. Mean
FSS score dropped from 6.4 to 5.0 (p<0.001). CFS
symptom pattern showed signiﬁcant less frequencies of
concentration and memory problems, headache,
myalgia, sleep disturbances at contact 2 compared to
contact 1 (all p<0.005), but no changes as to depres-
sion and arthralgia. A comparison between patients
with FSS ≥5 versus FSS<5 at contact 2 is shown in
tables 2 and 3.
Among 26 patients who reported improvement prior
to contact 1, 25 (96%) reported further improvement at
contact 2, whereas among 38 patients who reported wor-
sening or no change at contact 1, 23 (61%) reported
improvement at contact 2 (p=0.001).
Table 2 FSS score >5 or <5 on second follow-up (contact 2) and symptoms at contact 1
Number of patients FSS <5 FSS >5 p Value
Males 30 9 (25) 21 (39) 0.17
Females 60 27 (75) 33 (61)
Age debut of CFS 23.8 (7.9) 24.1 (7.0) 0.85
Age (second control) 33.6 (7.9) 35.8 (6.9) 0.17
First control (contact 1)
Age (first control) 26.8 (7.5) 29.3 (7.0) 0.11
FSS score (mean) 6.3 (1.2) 6.4 (.8) 0.63
Duration of CFS (years sum, mean) 3.3 (2.4) 5.6 (4.5) 0.006
Arthralgia 89 11 (33) 32 (59) 0.010
Myalgia 89 24 (69) 40 (74) 0.57
Headache 89 25 (71) 38 (70) 0.92
Sleeping disturbances 90 23 (64) 36 (67) 0.79
Depression 89 8 (23) 22 (41) 0.081
Concentration problems 89 32 (91) 50 (93) 0.84
Memory problems 90 30 (83) 41 (76) 0.40
Sore throat 90 22 (61) 26 (48) 0.23
Tender cervical lymph nodes 90 13 (36) 19 (35) 0.93
Physical activity: effect on fatigue 70 0.94
None 1 (3) 1 (3)
Worse 11 (38) 14 (35)
Much worse 17 (59) 25 (63)
Clinical change prior to first control 71 0.06
Improvement 16 (55) 12 (29)
No change 4 (14) 13 (31)
Worsening 9 (31) 17 (40)
Education 89 0.08
Primary school 2 (6) 7 (13)
High school 6 (17) 17 (32)
College or university 28 (78) 29 (55)
CFS, chronic fatigue syndrome; FSS, Fatigue Severity Scale.
Table 1 Symptoms on contact 1 and contact 2
Contact 1 Contact 2 p Value
FSS score, mean (SD) 6.4 (0.96) 5.0 (1.9) <0.001
Headache 61 (71) 47 (52) 0.033
Myalgia 65 (72) 52 (58) 0.042
Arthralgia 43 (48) 38 (42) 0.45
Sleep disturbances 60 (66) 47 (52) 0.048
Depression 30 (33) 25 (28) 0.42
Concentration problems 83 (92) 58 (64) <0.001
Memory problems 72 (79) 51 (56) <0.001
Sore throat 48 (53) 34 (37) 0.008
Tender cervical lymph
nodes
17 (19) 30 (33) 0.36
FSS, Fatigue Severity Score.
4 Nyland M, et al. BMJ Open 2014;4:e005798. doi:10.1136/bmjopen-2014-005798
Open Access
group.bmj.com on July 31, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
Logistic regression showed that FSS≥5 (versus FSS<5)
at contact 2 was associated with the following variables
registered at contact 1: arthralgia (OR=3.1, p=0.026),
depression (OR=4.0, p=0.029), duration of disease
(OR=1.2, p=0.043), and male sex (OR=2.6, p=0.087).
Linear regression analysis with FSS score at contact 2 as
dependent variable showed that arthralgia, depression
(both at contact 1) and level of education accounted for
22% of the variation of the FSS score (R2=0.22).
Disability was evaluated according to the WSAS, and
table 4 shows linear regression with WSAS score as
dependent variable and variables registered at contact
1. WSAS score was signiﬁcantly associated with depres-
sion, arthralgia, clinical change, PEM and level of educa-
tion (R2=0.28).
DISCUSSION
Our main ﬁnding was that about half of the patients
improved during the study period and were fully or
partly employed at the ﬁnal follow-up. This shows that
the occupational outcome is favourable in a consider-
able fraction of younger patients with CFS after on
average 5 years sickness absence from work. However,
the transition to partly (15 patients) or full (39 patients)
permanent disability pension shows that a substantial
proportion develop chronic incapacity for work with
severe negative consequences both for the individual
and for the wider society and economy.
Few studies have examined employment status over
time using operational criteria for CFS and standardised
measurements of disability and functioning to provide
information about the numbers of patients who were
functionally impaired and unable to work.13 To our
knowledge this study is the longest follow-up study of
CFS that has been published. Table 5 describes six
studies that examined work status over time. A long-term
follow-up study included 33 patients, mean age 43 years,
who answered identical questionnaires at diagnosis, after
4 years illness duration, and 5 years later. Work disability
was very high at baseline (77%) and increased to 91% at
5-year follow-up.23 A prospective study including 246
patients found little improvement in occupational status
after a follow-up period of 18 months. Before onset of
symptoms 141 (57%) patients worked. At initial assess-
ment 69 (28%) worked and 105 (43%) were on sick
leave or receiving disability beneﬁts. At follow-up 71
patients (29%) worked and 103 (42%) were on sick
leave. Self-reported improvement was indicated by
50 patients (20%), and 49 (20%) reported worsening of
symptoms.24 Another study reported the outcome for
35 patients with CFS (mean age 35 years) evaluated
42 months after the initial visit. Higher unemployment
rates were found at follow-up; 77% of patients versus
68% at baseline assessment.25
A few longitudinal studies have reported employ-
ment at baseline and follow-up after intervention.
A long-term study of cognitive behaviour therapy
versus relaxation therapy evaluated outcome at
5-year follow-up. A total of 68% of the 25 patients
who received cognitive therapy rated themselves as
improved compared to 36% of the 28 patients who
received relaxation therapy. Similar proportions of
patients were employed (56% vs 39%) but the patients
in the cognitive behaviour group worked more hours
per week (36 vs 24).26 In another study no treatment
effect of cognitive behaviour therapy as compared with
natural course was found on work rehabilitation
Table 4 Linear regression with WSAS as dependent
variable and variables registered at contact 1
β p Value
Sex <0.001 1.0
Age 0.16 0.17
Depression 0.27 0.026
Arthralgia 0.25 0.041
Clinical change −0.26 0.031
PEM −0.28 0.025
Education −0.27 0.021
PEM, post-exertional malaise; WSAS, Work and Social
Adjustment Scale.
Table 3 FSS score >5 or <5 on second follow-up and symptoms at contact 2
Number of
patients FSS<5 FSS>5 p Value
Age (second control) 92 33.6 (7.9) 35.8 (6.9) 0.17
Duration of CFS (years, mean) 90 10.1 (3.1) 12.1 (4.7) 0.028
Arthralgia 90 7 (19) 31 (57) <0.001
Myalgia 90 11 (31) 41 (76) <0.001
Headache 90 11 (31) 35 (65) 0.001
Sleeping disturbances 90 9 (25) 37 (69) <0.001
Depression 90 4 (11) 20 (37) 0.006
Concentration problems 90 14 (39) 43 (80) <0.001
Memory problems 90 12 (33) 38 (70) 0.001
Sore throat 90 12 (33) 22 (41) 0.48
Tender cervical lymph nodes 90 6 (17) 24 (44) 0.006
CFS, chronic fatigue syndrome; FSS, Fatigue Severity Scale.
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although self-rated improvement was associated with
cognitive behaviour treatment.27
A randomised controlled trial of patient education to
encourage graded exercise resulted in substantial self-
reported improvement in physical and occupational func-
tioning compared with standard medical care. The receipt
of sickness beneﬁt at the start of treatment was associated
with poor outcome.28 Occupational therapy with a lifestyle
management programme was offered to 74 patients after
median illness duration of 5 years. At follow-up 18 months
later 31 (42%) of the patients had returned to new
employment, voluntary work or training.29
A comprehensive review of the literature on the
natural course of CFS shows that the illness run a
chronic course in many sufferers and that less than 10%
of participants return to premorbid levels of function-
ing.30 Return to work after long-time sickness absence is
a complex process inﬂuenced by the severity of the dis-
order, personal factors, work-related factors and the
compensation system.
We found that all patients who were unemployed at
the initial examination received sickness or disability
beneﬁts. Norway has been criticised for high-disability
payments which may undermine motivation for
individuals to stay in work.31 A poor response to treat-
ment for CFS was predicted by being in receipt of sick-
ness beneﬁts in a patient education study.28 In
contrast, this study shows that long-term compensa-
tions to secure the socioeconomic position does not
inhibit return to work, but may be essential contribu-
tors to the high proportion becoming employed at
ﬁnal follow-up. In addition to the ﬁnancial support
the contact with the social security system initiates
rehabilitation activities directed towards obtaining new
work when unemployed.18
It is important to disclose predictors for long-term
outcome as this may suggest targets for management.
We found that arthralgia at the ﬁrst contact independ-
ently predicted poor long-term prognosis as evaluated
by employment, FSS and WSAS scores. Arthralgia is a
prominent and serious somatic symptom in the majority
of patients with CFS.4 We found that depression at the
ﬁrst contact tended to predict poor prognosis both as to
FSS and WSAS scores, but not employment. Pre-existing
depression is an exclusion criterion of CFS, but many
patients develop comorbid depression reactive to the
chronic illness that may contribute to a poorer prognosis
due to reduced illness coping.32 In contrast to our ﬁnd-
ings another study comprising 177 patients did not ﬁnd
any association between depression and ﬁnal outcome.33
We found that FSS score at the second contact was asso-
ciated with duration of illness disease at the ﬁrst contact.
This is compatible to the ﬁndings in a study of natural
course in CFS.34 As shown above reviews on predictors of
prognosis show conﬂicting results.13 This may be due to
major differences between studies. Important differences
include varying number of patients, severity of disease,
patient heterogeneity and length of follow-up. Two
strengths of the present study are the long-follow-up
period and the relatively high-response rate as to the
return of the postal questionnaire including details about
occupational status. This study differs from most others
because mononucleosis was a uniform trigger of CFS in all
patients. One limitation of the study is that the patients
were recruited from a tertiary centre and the patient
cohort may represent some selection bias. Whether the
written self-management programme contributed to
better outcome than expected is possible. This should be
addressed in controlled studies in the future.
In conclusion, about half of younger patients with CFS
with long-term incapacity for work got marked improve-
ment including full or part-time employment. Self-
management strategies, long-term sickness absence ben-
eﬁts providing a stable ﬁnancial support, in addition to
occupational interventions aimed at return to work were
likely contributors to the generally positive, prolonged
outcome. Risk factors for transition to permanent dis-
ability pension were depression, persistence of arthralgia
and disease duration.
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Table 5 Longitudinal assessment of employment status in chronic fatigue syndrome
Source Intervention
Time of follow-up
Months
Patients evaluated
for work status
Number
Patients employed at
baseline/follow-up
Number
Andersen et al23 None 60 33 23/9
Vercoulen et al24 None 18 246 28/29
Tiersky et al25 None 42 35 32/23
McDermott et al29 LMP 18 74 0/42
Deale et al26 CBT 60 25 *
Prins et al27 CBT 14 58 †
*Similar proportions of patients in cognitive behaviour therapy (CBT group; 56%) versus relaxation therapy control group (39%) were
employed at 5-year follow-up. CBT group patients worked more hours per week, 36 versus 24.
†Hours working in a job were similar in the CBT group and the natural course control group.
CBT, cognitive behaviour therapy; LMP, life management programme, occupational therapy.
6 Nyland M, et al. BMJ Open 2014;4:e005798. doi:10.1136/bmjopen-2014-005798
Open Access
group.bmj.com on July 31, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
Competing interests None.
Patient consent Obtained.
Ethics approval REK VEST, Norway.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available.
Open Access This is an Open Access article distributed in accordance with
the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license,
which permits others to distribute, remix, adapt, build upon this work non-
commercially, and license their derivative works on different terms, provided
the original work is properly cited and the use is non-commercial. See: http://
creativecommons.org/licenses/by-nc/4.0/
REFERENCES
1. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome:
a comprehensive approach to its definition and study. International
Chronic Fatigue Syndrome Study Group. Ann Intern Med
1994;121:953–9.
2. Salit IE. Precipitating factors for the chronic fatigue syndrome.
J Psychiatr Res 1997;31:59–65.
3. Reeves WC, Lloyd A, Vernon SD, et al. Identification of ambiguities
in the 1994 chronic fatigue syndrome research case definition and
recommendations for resolution. BMC Health Serv Res 2003;3:25.
4. Vincent A, Brimmer DJ, Whipple MO, et al. Prevalence, incidence,
and classification of chronic fatigue syndrome in Olmsted County,
Minnesota, as estimated using the Rochester Epidemiology Project.
Mayo Clin Proc 2012;87:1145–52.
5. Nacul LC, Lacerda EM, Pheby D, et al. Prevalence of myalgic
encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three
regions of England: a repeated cross-sectional study in primary care.
BMC Med 2011;9:91.
6. Wilson A, Hickie I, Hadzi-Pavlovic D, et al. What is chronic fatigue
syndrome? Heterogeneity within an international multicentre study.
Aust N Z J Psychiatry 2001;35:520–7.
7. Marmot M, Feeney A, Shipley M, et al. Sickness absence as a
measure of health status and functioning: from the UK Whitehall II
study. J Epidemiol Community Health 1995;49:124–30.
8. White PD, Thomas JM, Amess J, et al. Incidence, risk and
prognosis of acute and chronic fatigue syndromes and psychiatric
disorders after glandular fever. Br J Psychiatry 1998;173:475–81.
9. Katz BZ, Shiraishi Y, Mears CJ, et al. Chronic fatigue syndrome after
infectious mononucleosis in adolescents. Pediatrics
2009;124:189–3.
10. Taylor RR, Kielhofner GW. Work-related impairment and
employment-focused rehabilitation options for individuals with
chronic fatigue syndrome: a review. J Ment Health 2005;14:253–67.
11. Ware NC. Sociosomatics and illness in chronic fatigue syndrome.
Psychosom Med 1998;60:394–401.
12. Ross SD, Estok RP, Frame D, et al. Disability and chronic fatigue
syndrome: a focus on function. Arch Intern Med
2004;164:1098–107.
13. Cairns R, Hotopf M. A systematic review describing the prognosis of
chronic fatigue syndrome. Occup Med (Lond) 2005;55:20–31.
14. Naess H, Sundal E, Myhr KM, et al. Postinfectious and chronic
fatigue syndromes: clinical experience from a tertiary-referral centre
in Norway. In Vivo 2010;24:185–8.
15. Nijs J, Paul L, Wallman K. Chronic fatigue syndrome: an approach
combining self-management with graded exercise to avoid
exacerbations. J Rehabil Med 2008;40:241–7.
16. Cella M, Sharpe M, Chalder T. Measuring disability in patients with
chronic fatigue syndrome: reliability and validity of the work and
social adjustment scale. J Psychosom Res 2011;71:124–8.
17. Haukenes G, Aarli JA. [Postviral fatigue syndrome]. Tidsskr Nor
Laegeforen 1995;115:3017–22.
18. Gjesdal S, Bratberg E. Diagnosis and duration of sickness absence
as predictors for disability pension: results from a three-year,
multi-register based* and prospective study. Scand J Public Health
2003;31:246–54.
19. Van Ness J, Stevent S, Bateman L, et al. Postexertional malaise in
women with chronic fatigue syndrome. J Womens Health (Larchmt)
2010;19:239–44.
20. Krupp LB, LaRocca NG, Muir-Nash J, et al. The fatigue severity
scale. Application to patients with multiple sclerosis and systemic
lupus erythematosus. Arch Neurol 1989;46:1121–3.
21. Lerdal A, Wahl A, Rustoen T, et al. Fatigue in the general
population: a translation and test of the psychometric properties of
the Norwegian version of the fatigue severity scale. Scand J Public
Health 2005;33:123–30.
22. Mundt JC, Marks IM, Shear MK, et al. The work and social
adjustment scale: a simple measure of impairment in functioning.
Br J Psychiatry 2002;180:461–4.
23. Andersen MM, Permin H, Albrecht F. Illness and disability in Danish
Chronic Fatigue Syndrome patients at diagnosis and 5-year
follow-up. J Psychosom Res 2004;56:217–29.
24. Vercoulen JH, Swanink CM, Fennis JF, et al. Prognosis in chronic
fatigue syndrome: a prospective study on the natural course.
J Neurol Neurosurg Psychiatry 1996;60:489–4.
25. Tiersky LA, DeLuca J, Hill N, et al. Longitudinal assessment of
neuropsychological functioning, psychiatric status, functional
disability and employment status in chronic fatigue syndrome. Appl
Neuropsychol 2001;8:41–50.
26. Deale A, Husain K, Chalder T, et al. Long-term outcome of cognitive
behavior therapy versus relaxation therapy for chronic fatigue
syndrome: a 5-year follow-up study. Am J Psychiatry
2001;158:2038–42.
27. Prins JB, Bleijenberg G, Bazelmans E, et al. Cognitive behaviour
therapy for chronic fatigue syndrome: a multicentre randomised
controlled trial. Lancet 2001;357:841–7.
28. Bentall RP, Powell P, Nye FJ, et al. Predictors of response to
treatment for chronic fatigue syndrome. Br J Psychiatry
2002;181:248–52.
29. McDermott C, Richards SC, Ankers S, et al. An evaluation of a
chronic fatigue lifestyle management programme focusing on the
outcome of return to work or training. Br J Occup Ther
2004;67:269–73.
30. Joyce J, Hotopf M, Wessely S. The prognosis of chronic fatigue
and chronic fatigue syndrome: a systematic review. QJM
1997;90:223–3.
31. Markussen S, Roed K, Rogeberg OJ, et al. The anatomy of
absenteeism. J Health Econ 2011;30:277–92.
32. Lawn T, Kumar P, Knight B, et al. Psychiatric misdiagnoses in
patients with chronic fatigue syndrome. JRSM Short Rep 2010;1:28.
33. Pheley AM, Melby D, Schenck C, et al. Can we predict recovery in
chronic fatigue syndrome? Minn Med 1999;82:52–6.
34. van der Werf SP, de Vree B, Alberts M, et al. Natural course and
predicting self-reported improvement in patients with chronic fatigue
syndrome with a relatively short illness duration. J Psychosom Res
2002;53:749–53.
Nyland M, et al. BMJ Open 2014;4:e005798. doi:10.1136/bmjopen-2014-005798 7
Open Access
group.bmj.com on July 31, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
after mononucleosis
in patients with chronic fatigue syndrome 
Longitudinal follow-up of employment status
Morten Nyland, Halvor Naess, Jon Steinar Birkeland and Harald Nyland
doi: 10.1136/bmjopen-2014-005798
2014 4: BMJ Open 
 http://bmjopen.bmj.com/content/4/11/e005798
Updated information and services can be found at: 
These include:
References
 #BIBLhttp://bmjopen.bmj.com/content/4/11/e005798
This article cites 34 articles, 14 of which you can access for free at: 
Open Access
http://creativecommons.org/licenses/by-nc/4.0/non-commercial. See: 
provided the original work is properly cited and the use is
non-commercially, and license their derivative works on different terms, 
permits others to distribute, remix, adapt, build upon this work
Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
This is an Open Access article distributed in accordance with the Creative
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (304)Infectious diseases
 (166)Health economics
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on July 31, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
